These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19418954)

  • 1. Aerosol devices and asthma therapy.
    Berger W
    Curr Drug Deliv; 2009 Jan; 6(1):38-49. PubMed ID: 19418954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent development of drug delivery systems for the treatment of asthma and related disorders.
    Takizawa H
    Recent Pat Inflamm Allergy Drug Discov; 2009 Nov; 3(3):232-9. PubMed ID: 19663776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
    Roche N; Dekhuijzen PN
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
    Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
    Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology.
    Acerbi D; Brambilla G; Kottakis I
    Pulm Pharmacol Ther; 2007; 20(3):290-303. PubMed ID: 16890465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol delivery devices in the treatment of asthma.
    Hess DR
    Respir Care; 2008 Jun; 53(6):699-723; discussion 723-5. PubMed ID: 18501026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.
    Dolovich MB; Ahrens RC; Hess DR; Anderson P; Dhand R; Rau JL; Smaldone GC; Guyatt G; ;
    Chest; 2005 Jan; 127(1):335-71. PubMed ID: 15654001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metered-dose inhalers, dry powder inhalers, and transitions.
    Fink JB
    Respir Care; 2000 Jun; 45(6):623-35. PubMed ID: 10894455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is new in asthma: new dry powder inhalers.
    Hannemann LA
    J Pediatr Health Care; 1999; 13(4):159-65. PubMed ID: 10690079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of inhaler devices containing beta(2)-agonist bronchodilators in the treatment of asthma: cochrane systematic review and meta-analysis of more than 100 randomized, controlled trials.
    Ram FS
    Am J Respir Med; 2003; 2(4):349-65. PubMed ID: 14720001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma.
    Ram FS; Brocklebank DM; White J; Wright JP; Jones PW
    Cochrane Database Syst Rev; 2002; 2002(1):CD002158. PubMed ID: 11869625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of inhaler devices in pediatric asthma.
    De Benedictis FM; Selvaggio D
    Paediatr Drugs; 2003; 5(9):629-38. PubMed ID: 12956619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.